No complications with risperidone treatment before and throughout pregnancy and during the nursing period [3]

Journal of Clinical Psychiatry

Volumn 63, Issue 1, 2002, Pages 76-77

  Ratnayake, T ^a   Libretto, Susan E ^a  

^a Harry Watton House   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

RISPERIDONE;

ADULT; BREAST FEEDING; CASE REPORT; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; LETTER; PREGNANCY; PRENATAL EXPOSURE; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; SCHIZOPHRENIA; SIDE EFFECT; TERATOGENICITY;

EID: 0036157162     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v63n0114c     Document Type: Letter

References (17)

1. Depression in women: Implications for healthcare research
2. Antipsychotic use in pregnancy: What are the best treatment options?
3. Psychotropic drug use during pregnancy: Weighing the risks
4. Obstetric complications in children born to parents with schizophrenia: A meta-analysis of case control studies
5. Treatment and outcomes of psychotic patients during pregnancy and childbirth
6. Psychotic denial of pregnancy: Phenomenology and clinical management
7. Course of psychiatric disorders in pregnancy
8. Psychotropic medications in pregnant women: Treatment dilemmas
9. Pregnancy and clozapine
10. Clozapine use in two full-term pregnancies
11. Pregnancy of a patient treated with clozapine
12. Olanzapine and pregnancy
13. Healthy outcome under olanzapine treatment in a pregnant woman
14. Antipsychotics during pregnancy
15. The safety of risperidone: A post-marketing study on 7684 patients
16. Risperdal SPC
17. Risperidone distribution and excretion into human milk: Case report and estimated infant exposure during breast-feeding